Form 4 for CL Colgate-Palmolive
Accepted 2024-02-02 00:00:00 ET · period of report 2024-01-31 · accession 0001225208-24-001484 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-02 | 2024-01-31 | CL | HARRIS C MARTIN | Dir | M - OptEx | $62.04 | +2,760 | 22.0K | +14% | +$171.2K |
| D | 2024-02-02 | 2024-01-31 | CL | HARRIS C MARTIN | Dir | S - Sale+OE | $84.50 | -2,760 | 19.3K | -13% | -$233.2K |
| D | 2024-02-02 | 2024-01-31 | CL | HARRIS C MARTIN | Dir | M - OptEx | $0.00 | -2,760 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-31 | M | A | 2,760 | $62.04 | 22,032 | D | — | — | |
| 2 | Common | Common Stock | 2024-01-31 | S | D | 2,760 | $84.50 | 19,272 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-01-31 | M | D | 2,760 | $0.00 | 0 | D | $62.04 · — to 2024-05-14 | 2,760 Common Stock | (F3) Option became exercisable in one-third increments beginning on the first anniversary of the May 14, 2018 grant date. |